Smith & Nephew plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on December 6, 2024, serves as a notification and public disclosure in accordance with the EU Market Abuse Regulation. It reports transactions by persons discharging managerial responsibilities, specifically the vesting of equity awards for Deepak Nath, the Chief Executive Officer.
Key Financial Metrics
The filing does not provide financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific equity transaction.
Material Changes and Transaction Details
On December 5, 2024, equity awards granted on April 29, 2022, vested for Deepak Nath. The transaction details are as follows:
- Instrument: Smith & Nephew plc ordinary shares (USD 0.20 each).
- Total Shares Vested: 83,057 shares.
- Performance Award Outcome: Of the original 97,360 shares, 77.29% (75,254 shares) vested based on Siemens Healthineers AG performance criteria; 22,106 shares lapsed.
- Restricted Share Awards: Additional awards totaling 7,803 shares (originally scheduled for November 2024) were included in this vesting event.
- Transaction Price: £9.812 per share.
- Disposition: 34,033 shares were sold to cover tax obligations, and 49,024 shares were retained.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a regulatory disclosure of a completed equity event.
Key Facts for Investor Verification
- Verify the final share count retained by the CEO (49,024 shares) versus the total vested amount.
- Confirm the performance criteria linkage to Siemens Healthineers AG financial results announced on November 6, 2024.
- Note that the vesting date was delayed from November 2024 to December 5, 2024, to align with the performance measurement period.